14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
KEQU vs KTEC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over KraneShares Hang Seng TECH Index ETF (KTEC) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KEQU carries a Unified Composite Score of 36.1/100 (SELL) at $35.05 (7.7x Forward P/E, 5.4% operating margin), whereas KTEC carries 45.3/100 (HOLD) at $10.68 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While KTEC currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. KEQU 36.1/100 SELL), KEQU captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (5.4% vs. N/A operating margin) and revenue trajectory (-6.7% vs. N/A YoY).
Technical & Structure Timing Caution: KEQU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.2); meanwhile KTEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KEQU vs KTEC. Trailing 12-month operating profitability (KEQU 5.4% vs KTEC N/A) and valuation multiples (KEQU 7.7x vs KTEC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ KEQU vs KTEC Key Questions & Quantitative Answers
As of Nov 16, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over KraneShares Hang Seng TECH Index ETF (KTEC) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KEQU carries a Unified Composite Score of 36.1/100 (SELL) at $35.05 (7.7x Forward P/E, 5.4% operating margin), whereas KTEC carries 45.3/100 (HOLD) at $10.68 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While KTEC currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. KEQU 36.1/100 SELL), KEQU captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (5.4% vs. N/A operating margin) and revenue trajectory (-6.7% vs. N/A YoY). Technical & Structure Timing Caution: KEQU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.2); meanwhile KTEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KEQU leads the Growth & Scale pillar: KEQU posts -6.7% YoY revenue growth and -44.2% YoY earnings growth on $277M TTM revenue (28.6% gross margin, 5.4% operating margin), compared with KTEC at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, KEQU generates $277M in USD-normalized revenue versus N/A for KTEC. In operating R&D and SG&A reinvestment, KEQU deploys 23.2% of Rev ($64M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KTEC.
KEQU screens cheaper on headline valuation multiples. KEQU trades at 7.7x Forward P/E, 12.9x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (7.7% EBITDA margin), whereas KTEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KEQU (12.5% ROE) versus KTEC (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, KEQU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 38% Vol realized risk). By comparison, KTEC carries 30.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.75β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.